"Cell Movement" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell.
| Descriptor ID |
D002465
|
| MeSH Number(s) |
G04.198 G07.568.500.180
|
| Concept/Terms |
Cell Movement- Cell Movement
- Cell Movements
- Movements, Cell
- Movement, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Movement".
Below are MeSH descriptors whose meaning is more specific than "Cell Movement".
This graph shows the total number of publications written about "Cell Movement" by people in this website by year, and whether "Cell Movement" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 8 | 9 |
| 1996 | 2 | 3 | 5 |
| 1997 | 2 | 8 | 10 |
| 1998 | 3 | 2 | 5 |
| 1999 | 4 | 2 | 6 |
| 2000 | 2 | 5 | 7 |
| 2001 | 3 | 11 | 14 |
| 2002 | 5 | 8 | 13 |
| 2003 | 3 | 9 | 12 |
| 2004 | 5 | 10 | 15 |
| 2005 | 6 | 11 | 17 |
| 2006 | 4 | 17 | 21 |
| 2007 | 7 | 19 | 26 |
| 2008 | 11 | 20 | 31 |
| 2009 | 6 | 25 | 31 |
| 2010 | 11 | 24 | 35 |
| 2011 | 8 | 14 | 22 |
| 2012 | 2 | 23 | 25 |
| 2013 | 11 | 25 | 36 |
| 2014 | 7 | 25 | 32 |
| 2015 | 8 | 31 | 39 |
| 2016 | 13 | 25 | 38 |
| 2017 | 6 | 28 | 34 |
| 2018 | 3 | 25 | 28 |
| 2019 | 3 | 14 | 17 |
| 2020 | 3 | 23 | 26 |
| 2021 | 3 | 21 | 24 |
| 2022 | 2 | 9 | 11 |
| 2023 | 0 | 4 | 4 |
| 2024 | 1 | 10 | 11 |
| 2025 | 2 | 12 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Movement" by people in Profiles.
-
Exploring the Therapeutic Potential of Salivary Exosomes in Corneal Epithelial Wound Healing. Invest Ophthalmol Vis Sci. 2025 Aug 01; 66(11):8.
-
Contribution of NLRP3-GSDMD axis to PDGF-BB-induced vascular smooth muscle cell phenotypic transition. Am J Physiol Cell Physiol. 2025 Aug 01; 329(2):C682-C698.
-
Disruption of the Nucleolin-CXCR4 interaction by the DNA aptamer HY-4 halts colorectal cancer metastasis. Mol Ther. 2025 Oct 01; 33(10):4904-4922.
-
Human Extravillous Trophoblasts Require SRC-2 for Sustained Viability, Migration, and Invasion. Cells. 2025 Jul 04; 14(13).
-
Immature Acta2R179C/+ smooth muscle cells cause moyamoya-like cerebrovascular lesions in mice prevented by boosting OXPHOS. Nat Commun. 2025 Jul 02; 16(1):6105.
-
The splicing factor kinase SRPK1 is a therapeutic target for peripheral vascular disease. Am J Physiol Heart Circ Physiol. 2025 Aug 01; 329(2):H490-H504.
-
Retinal ganglion cell migration and viability requires the kinase LKB1. J Cell Biol. 2025 Jul 07; 224(7).
-
Exploring the regulatory mechanism of CCNA2 in colorectal cancer: Insights from multiomics and experimental analysis. J Biol Chem. 2025 Aug; 301(8):110216.
-
Screening and identification of versican as a sensitive biomarker and potential therapeutic target in basal cell carcinoma. Int J Med Sci. 2025; 22(10):2488-2501.
-
Dichotomous roles of ACBD3 in NSCLC growth and metastasis. Oncogene. 2025 Jul; 44(25):2078-2090.